Author:
Stanley Michael,Lautin Andrew,Rotrosen John,Gershon Samuel,Kleinberg David
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Bateman D, Kahn C, Legg N, Reid J (1978) Metoclopramide in Parkinson's disease. Clin Pharmacol Ther 24:459?464
2. Borenstein P, Bles G (1965) Effects cliniques et electro-encephalographiques du metoclopramide en psychiatrie. Therapie 20:975?995
3. Byck R (1975) Drugs and the treatment of psychiatric disorders. In: Goodman L, Gilman A (eds) The pharmacological basis of Therapeutics. MacMillan, New York, p 152
4. Costall B, Naylor R (1976a) Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine. Eur J Pharmacol 35:161?168
5. Costall B, Naylor R (1976b) A Comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride, and metoclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems. Eur J Pharmacol 40:9?19
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献